However, since no measurements of splanchnic hemodynamic changes after more long-term exposure to GIP receptor antagonism have been conducted, in either animal models or humans, the therapeutic implications of this effect are uncertain
This can sometimes lead to what's known as a Herxheimer reaction, or a 'healing crisis.' As toxins are mobilized from tissues and flushed out of the body, they can cause temporary symptoms like headaches, fatigue, skin rashes, andyou guessed itdigestive upset
Proactive peptide use potentially delaying or preventing disease onset
Some need longer medical supervision than others
Wegovy is a glucagon-like peptide-1 receptor agonist (also known as GLP-1 receptor agonist or GLP-1 RA), which bagged US Food and Drug Administrations approval as a treatment for obesity in June 2021